13-Mar-2026
BrainsWay at an all-time high on Q4 beat, upside guidance
Seeking Alpha News (Wed, 11-Mar 1:17 PM ET)
BrainsWay Reports Q4 Earnings: Revenue Beat, Guidance Below Estimates
Benzinga (Wed, 11-Mar 9:18 AM ET)
BrainsWay Posts Record 2025 Results and Issues Bullish 2026 Outlook on Deep TMS Momentum
TipRanks (Wed, 11-Mar 7:57 AM ET)
BrainsWay GAAP EPS of $0.07 beats by $0.04, revenue of $14.55M beats by $0.53M
Seeking Alpha News (Wed, 11-Mar 7:31 AM ET)
BrainsWay Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
Globe Newswire (Wed, 11-Mar 7:30 AM ET)
Here are the major earnings before the open Wednesday
Seeking Alpha News (Tue, 10-Mar 6:00 PM ET)
Brainsway’s New Deep TMS Depression Study Completion: What Investors Should Watch Next
TipRanks (Tue, 10-Mar 12:30 PM ET)
BrainsWay Q4 2025 Earnings Preview
Seeking Alpha News (Tue, 10-Mar 11:01 AM ET)
Landmark Data Validate BrainsWay's SWIFT Deep TMS, Beginning a New Era in Depression Treatment
Globe Newswire (Wed, 4-Mar 7:30 AM ET)
BrainsWay to Report Fourth Quarter and Full Year 2025 Financial Results on March 11, 2026
Globe Newswire (Wed, 25-Feb 8:00 AM ET)
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
Brainsway Ltd. - American Depositary Shares trades on the NASDAQ stock market under the symbol BWAY.
As of March 13, 2026, BWAY stock price declined to $13.71 with 225,656 million shares trading.
BWAY has a beta of 0.40, meaning it tends to be less sensitive to market movements. BWAY has a correlation of 0.01 to the broad based SPY ETF.
BWAY has a market cap of $268.83 million. This is considered a Small Cap stock.
Last quarter Brainsway Ltd. - American Depositary Shares reported $15 million in Revenue and $.04 earnings per share. This beat revenue expectation by $534,200 and missed earnings estimates by -$.01.
In the last 3 years, BWAY traded as high as $14.65 and as low as $.35.
The top ETF exchange traded funds that BWAY belongs to (by Net Assets): IZRL, APIE, EHLS.
BWAY has outperformed the market in the last year with a price return of +437.1% while the SPY ETF gained +21.4%. BWAY has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +223.3% and +137.0%, respectively, while the SPY returned -2.6% and -3.5%, respectively.
BWAY support price is $13.09 and resistance is $14.39 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BWAY shares will trade within this expected range on the day.